Wednesday, November 24, 2010

Hepatitis C News : Nov 24th

The Art of Reading Newspapers

A few important links folks:
FAQ : What You Need To Know About Telaprevir
Telaprevir FDA Submission Complete Seeking Approval Asking For Priority Review

From the new website:
Hepatitis C Nonresponders
Hepatitis C Test: Likeihood Of Achieving SVR/

Iran increases term of Azerbaijanis' visa-free stay
Azerbaijani citizens, traveling to Iran, must take a blood test for hepatitis C and AIDS

Today from HIV and Hepatitis;
Long-term Viral Suppression with Telaprevir Combination Therapy, Resistance Declines over Time

Effectiveness and Safety of Tenofovir in Real-world Clinical Practice

From Medical News Today
EDDA Technology Introduces IQQA®-Liver Suite To Provide Dedicated Total Solutions For Liver Cancer Diagnosis And Treatment Management
24 November 2010EDDA Technology announced that it will introduce its innovative IQQA®-Liver Suite, which provides dedicated total solutions for liver cancer diagnosis and operative treatment management, at the 96th Scientific Assembly...
[read article]

From Medpage
Abnormal Liver Enzymes No Reason to Avoid Statins
Statins are not only safe and effective for patients with liver enzyme abnormalities but also appear to improve their liver function, researchers found.

Big Jump in Diabetes Incidence Expected in Next Decade
2 hours ago By the year 2020, 52% of adults in the U.S. could be prediabetic or diabetic, up from about 40% today, a new report predicted.

From Medscape
Major and Notable Cancer Advances in 2010
Medscape Medical News, November 24, 2010

From The Medical News;
ViiV Healthcare awards $20 million to Idenix for GSK2248761 clinical milestone
23. November 2010 23:24
Idenix Pharmaceuticals, Inc, a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that the Company will receive a payment of $20 million from the ViiV Healthcare Company for the achievement of a clinical milestone relating to GSK2248761.

Liver Cancer
Using Lasers to Treat Kidney and Liver Tumors
FAITH LAPIDUS: Doctors at the Mayo Clinic are using a process known as MRI-guided laser ablation to fight kidney and liver tumors. They are said to be among the first American doctors to use the process against the cancers.

Liver cancer is one of the most common cancers in the world. It is also the third leading cause of cancer death worldwide. Many liver cancer patients are too sick to survive traditional treatments, like chemotherapy and radiation. Even if they could, medical experts say these treatments only provide a small increase in life expectancy.

EDDA Technology Introduces IQQA®-Liver Suite To Provide Dedicated Total Solutions for Liver Cancer Diagnosis and Treatment Management
PRINCETON, N.J., Nov. 23, 2010 /PRNewswire/ -- EDDA Technology announced today that it will introduce its innovative IQQA®-Liver Suite, which provides dedicated total solutions for liver cancer diagnosis and operative treatment management, at the 96th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). For better healthcare and patient management, the IQQA®-Liver Suite aims to enhance efficiency and precision in liver disease diagnosis, pre-operative treatment planning, intra-operative guidance, post-surgical assessment and follow-up.

In Case You Missed It
Apricus seeks quick route for liver cancer treatment
Apricus Biosciences asked federal regulators Monday for permission to skip Phase 2 clinical trials of its experimental liver cancer drug and launch late-stage studies of the therapy in terminal patients.

ACOG Issues Guidelines for Care of Women With HIV
November 23, 201027 percent of HIV-positive/AIDS cases in U.S. are women, most in reproductive years

UNAIDS reports real evidence of progress in global response to HIV 23 November 2010

Drug Combination May Prevent HIV Acquisition

November 23, 2010Taking the antiretroviral drugs daily appears effective in men who have sex with men

Stem Cells
Discovery halts breast cancer stem cells
Breast cancer stem cells, the aggressive cells thought to be resistant to current anti-cancer therapies and which promote metastasis, are stimulated by estrogen via a pathway that mirrors normal stem cell development. Disrupting the pathway, researchers were able to halt the expansion of breast CSCs, a finding that suggests a new drug therapy target. The study, done in mice, is published in the Proceedings of the National Academy of Sciences early edition. Breast Cancer Research Foundation, Raymond and Beverly Sackler Foundation, NIH/National Cancer Institute, NIH/National Institute of General Medical Sciences, New England Division of the American Cancer Society
Contact: Siobhan E. Gallagher

Other Health News
Easy on the Salt!
Posted: Tue, 23 Nov 2010 13:45:00 EST
There can be far more salt in many holiday meals than people realize, and the proof can be found at hospital emergency rooms. Heart problems aggravated or unmasked after ingestion of a significant amount of salt tend to make holidays such as Thanksgiving, Passover and Christmas very busy times for health providers like University of Medicine and Dentistry of New Jersey (UMDNJ) cardiologist Marc Klapholz, M.D., F.A.C.C. Here, Klapholz and UMDNJ Registered Dietitian Lauren Kolesa share tips for preparing and enjoying the holidays

Do You Think Your Doctor Would Tell You if a Medical Error Occurred?
Posted: Tue, 23 Nov 2010 09:00:00 EST
People who believe their doctor or hospital would inform them if a medical error occurred are "far more forgiving" than those who doubt their health care provider would disclose the error, reports a study in the November issue of Medical Care. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

No comments:

Post a Comment